4:54 PM
 | 
Apr 12, 2013
 |  BC Extra  |  Top Story

Durata raises $50.1 million in follow-on

Infectious disease company Durata Therapeutics Inc. (NASDAQ:DRTX) raised $50.1 million through the sale of 7.2 million shares at $7 in a follow-on underwritten by BofA Merrill Lynch; Credit...

Read the full 121 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >